MedPath

MedeonBio, Inc.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Safety and Feasibility of the XFLO Expander System (Mercury)

Not Applicable
Active, not recruiting
Conditions
Benign Prostatic Hyperplasia
Interventions
Device: XFLO Expander System
First Posted Date
2018-11-29
Last Posted Date
2022-07-26
Lead Sponsor
MedeonBio, Inc.
Target Recruit Count
45
Registration Number
NCT03758222
Locations
🇬🇪

National Center of Urology, Tbilisi, Georgia

🇨🇳

China Medical University Hospital, Taichung, Taiwan

🇨🇦

University Health Network, Toronto, Ontario, Canada

and more 2 locations
© Copyright 2025. All Rights Reserved by MedPath